Patient-centered decision support in acute ischemic stroke: Qualitative study of patients' and providers' perspectives

Circulation: Cardiovascular Quality and Outcomes

Volumn 8, Issue 6_suppl_3, 2015, Pages S109-S116

  Decker, Carole ^a,c   Chhatriwalla, Emily ^c   Gialde, Elizabeth ^c   Garavalia, Brian ^c   Summers, Debbie ^c   Quinlan, Miriam E ^d   Cheng, Eric ^d   Rymer, Marilyn ^e   Saver, Jeffrey L ^d   Chen, Er ^f   Kent, David M ^g   Spertus, John A ^b,c  

^a Medical College   (United States)

^b School of Medicine   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Kansas   (United States)

^f GENENTECH INC   (United States)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

caregivers; intracranial hemorrhage; stroke; survivors; treatment outcome

Indexed keywords

ADULT; ADVANCED PRACTICE NURSE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAREGIVER; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; EMERGENCY MEDICINE; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; ACUTE DISEASE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; MIDDLE AGED; PATIENT; PATIENT EDUCATION; RISK ASSESSMENT; STROKE;

FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BRAIN ISCHEMIA; CAREGIVERS; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; FEMALE; FIBRINOLYTIC AGENTS; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT-CENTERED CARE; PATIENTS; RECOMBINANT PROTEINS; RISK ASSESSMENT; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84945964477     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.002003     Document Type: Article

References (48)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 322. doi: 10.1161/CIR.0000000000000152
2. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J, Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988 19 604 607
3. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 333 1581 1587
4. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995 274 1017 1025
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998 352 1245 1251
6. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S, Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999 282 2019 2026
7. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM, EPITHET investigators Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008 7 299 309. doi: 10.1016/S1474-4422(08)70044-9
8. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 44 870 947. doi: 10.1161/STR.0b013e318284056a
9. Edlow J, Smith E, Stead L, Gronseth G, Messé S, Jagoda A, Wears R, Decker W, American College of Emergency Physicians and American Academy of Neurology Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med 2013 61 225 243
10. American College of Emergency Physicians ACEP to Reconsider Clinical Policy on Use of Intravenous tPA to Manage Acute Ischemic Stroke in the ED. http://www.acepnow.com/articleacep-council-votes-reconsider-clinical-policy-use-intravenous-tpa-manage-acute-ischemic-stroke-ed/. 2014; Accessed August 14, 2015
11. Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH, Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013 309 2480 2488. doi: 10.1001/jama.2013.6959
12. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP, Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000 55 1649 1655
13. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 768 774. doi: 10.1016/S0140-6736(04)15692-4
14. Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC, Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 2013 6 543 549. doi: 10.1161/CIRCOUTCOMES.111.000303
15. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, Hernandez AF, Peterson ED, Schwamm LH, GWTG-Stroke Steering Committee and Investigators Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes 2010 3 291 302. doi: 10.1161/CIRCOUTCOMES.109.921858
16. Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH, Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014 311 1632 1640. doi: 10.1001/jama.2014.3203
17. Weimar C, Ziegler A, König IR, Diener HC, Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002 249 888 895. doi: 10.1007/s00415-002-0755-8
18. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W, The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke 2006 37 2957 2962. doi: 10.1161/01.STR.0000249054.96644.c6
19. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W, Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window? Stroke 2006 37 2963 2969. doi: 10.1161/01.STR.0000249005.37120.9f
20. Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, Engelter S, Tatlisumak T, Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology 2012 78 427 432. doi: 10.1212/WNL.0b013e318245d2a9
21. Strbian D, Michel P, Seiffge DJ, Saver JL, Numminen H, Meretoja A, Murao K, Weder B, Forss N, Parkkila AK, Eskandari A, Cordonnier C, Davis SM, Engelter ST, Tatlisumak T, Symptomatic intracranial hemorrhage after stroke thrombolysis: comparison of prediction scores. Stroke 2014 45 752 758. doi: 10.1161/STROKEAHA.113.003806
22. König IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, Diener HC, Weimar C, Virtual International Stroke Trials Archive (VISTA) Investigators Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008 39 1821 1826. doi: 10.1161/STROKEAHA.107.505867
23. Saposnik G, Guzik AK, Reeves MJ, Ovbiagele B, Johnston SC, Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology 2013 80 21 28. doi: 10.1212/WNL.0b013e31827b1ace
24. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P, An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology 2012 78 1916 1922. doi: 10.1212/WNL.0b013e318259e221
25. Saposnik G, Kapral MK, Liu Y, Hall R, O'Donnell M, Raptis S, Tu JV, Mamdani M, Austin PC, Investigators of the Registry of the Canadian Stroke Network; Stroke Outcomes Research Canada (SORCan) Working Group IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation 2011 123 739 749. doi: 10.1161/CIRCULATIONAHA.110.983353
26. Soto GE, Jones P, Spertus JA, PRISM™: a web-based framework for deploying predictive clinical models. Computers in Cardiology 2004 31 193 196
27. Soto GE, Spertus JA, EPOCH and ePRISM: a web-based translational framework for bridging outcomes research and clinical practice. Computers in Cardiology 2007 34 205 208
28. Kent DM, Ruthazer R, Decker C, Jones PG, Saver JL, Bluhmki E, Spertus JA, Development and validation of a simplified Stroke-Thrombolytic Predictive Instrument. Neurology 2015 85 942 949. doi: 10.1212/WNL.0000000000001925
29. Institute of Medicine Crossing the Quality Chasm: A New Health System for the Twenty-First Century 2001 Washington, DC National Academy Press
30. Flynn D, Knoedler MA, Hess EP, Murad MH, Erwin PJ, Montori VM, Thomson RG, Engaging patients in health care decisions in the emergency department through shared decision-making: a systematic review. Acad Emerg Med 2012 19 959 967. doi: 10.1111/j.1553-2712.2012.01414.x
31. Gadhia J, Starkman S, Ovbiagele B, Ali L, Liebeskind D, Saver JL, Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis. Stroke 2010 41 300 306. doi: 10.1161/STROKEAHA.109.566935
32. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA, Patient preferences for stroke outcomes. Stroke 1994 25 1721 1725
33. Knapp P, Wanklyn P, Raynor DK, Waxman R, Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract 2010 18 362 369. doi: 10.1111/j.2042-7174.2010.00060.x
34. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010 375 1695 1703. doi: 10.1016/S0140-6736(10)60491-6
35. Educating Stroke Patients and Families Activase for Acute Ischemic Stroke. http://www.activase.com/iscstroke/educating-stroke-patients-fam/resources. 2014; Accessed August 28, 2013
36. Position Statement on the Use of Intravenous Thrombolytic Therapy in the Treatment of Stroke American Academy of Emergency Medicine. http://www.aaem.org/em-resources/position-statements/clinical-practice/thrombolytic-therapy. 2002; Accessed October 18, 2012
37. Marshall MN, Sampling for qualitative research. Fam Pract 1996 13 522 525
38. Elo S, Kyngäs H, The qualitative content analysis process. J Adv Nurs 2008 62 107 115. doi: 10.1111/j.1365-2648.2007.04569.x
39. Sless D, Wiseman R, Writing about Medicines for People. Canberra: Department of Health and Family Services 1997
40. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T, International Patient Decision Aids Standards (IPDAS) Collaboration Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006 333 417. doi: 10.1136/bmj.38926.629329.AE
41. Cheng E, Quinlan M, Gialde E, Chhatriwalla E, Spertus JA, Rymer M, Summers D, Saver J, Decker C, What stroke survivors and families need to know for decision-making during acute ischemic stroke care: A qualitative research study. 2013 American Heart Association/American Stroke Association International Stroke Conference Honolulu, HI
42. Menon BK, Saver JL, Prabhakaran S, Reeves MJ, Liang L, Olson DM, Peterson ED, Hernandez AF, Fonarow GC, Schwamm LH, Smith EE, Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 2012 43 2293 2299. doi: 10.1161/STROKEAHA.112.660415
43. Singer OC, Dvorak F, du Mesnil de Rochemont R, Lanfermann H, Sitzer M, Neumann-Haefelin T, A simple 3-item stroke scale: comparison with the National Institutes of Health Stroke Scale and prediction of middle cerebral artery occlusion. Stroke 2005 36 773 776. doi: 10.1161/01.STR.0000157591.61322.df
44. Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL, Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009 40 2079 2084. doi: 10.1161/STROKEAHA.108.540708
45. Lie ML, Murtagh MJ, Watson DB, Jenkings KN, Mackintosh J, Ford GA, Thomson RG, Risk communication in the hyperacute setting of stroke thrombolysis: an interview study of clinicians. Emerg Med J 2015 32 357 363. doi: 10.1136/emermed-2014-203717
46. Scott PA, Meurer WJ, Frederiksen SM, Kalbfleisch JD, Xu Z, Haan MN, Silbergleit R, Morgenstern LB, INSTINCT Investigators A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. Lancet Neurol 2013 12 139 148. doi: 10.1016/S1474-4422(12)70311-3
47. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Use of Intravenous tPA for Ischemic Stroke Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department. http://www.acep.org/workarea/DownloadAsset.aspx?id=102612. 2015; Accessed August 14, 2015
48. Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C, Myocardial infarction, stroke, and mortality in cART-treated HIV patients on statins. AIDS Patient Care STDS 2015 29 307 313. doi: 10.1089/apc.2014.0309